NCT04339881View on ClinicalTrials.gov

NOsocomial Dissemination Risk of SARS-Cov2

CompletedOBSERVATIONAL
Enrollment

2,523

Participants

Timeline

Start Date

April 17, 2020

Primary Completion Date

July 10, 2020

Study Completion Date

July 12, 2020

Conditions
Sars-CoV2
Trial Locations (1)

Unknown

Didier Guillemot, Garches

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT04339881 - NOsocomial Dissemination Risk of SARS-Cov2 | Biotech Hunter | Biotech Hunter